Ratio Analysis: Unpacking Dexcom Inc (DXCM)’s Price-to-Cash and Price-to-Free Cash Flow

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $69.00 in the prior trading day, Dexcom Inc (NASDAQ: DXCM) closed at $68.61, down -0.57%. In other words, the price has decreased by -$0.57 from its previous closing price. On the day, 5.14 million shares were traded. DXCM stock price reached its highest trading level at $70.135 during the session, while it also had its lowest trading level at $67.895.

Ratios:

Our goal is to gain a better understanding of DXCM by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 50.09. For the most recent quarter (mrq), Quick Ratio is recorded 2.12 and its Current Ratio is at 2.46. In the meantime, Its Debt-to-Equity ratio is 1.31 whereas as Long-Term Debt/Eq ratio is at 1.30.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on July 26, 2024, Downgraded its rating to Neutral and sets its target price to $80 from $161 previously.

On July 26, 2024, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $145 to $75.

On May 30, 2024, Redburn Atlantic started tracking the stock assigning a Neutral rating and target price of $130.Redburn Atlantic initiated its Neutral rating on May 30, 2024, with a $130 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 16 ’24 when Heller Bridgette P sold 1,000 shares for $70.00 per share. The transaction valued at 70,000 led to the insider holds 24,349 shares of the business.

Heller Bridgette P bought 1,000 shares of DXCM for $70,000 on Sep 16 ’24. On Sep 09 ’24, another insider, Stern Sadie, who serves as the EVP, Chief HR Officer of the company, sold 426 shares for $69.15 each. As a result, the insider received 29,458 and left with 75,451 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DXCM now has a Market Capitalization of 26951106560 and an Enterprise Value of 26897649664. As of this moment, Dexcom’s Price-to-Earnings (P/E) ratio for their current fiscal year is 41.13, and their Forward P/E ratio for the next fiscal year is 33.81. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.79. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.78 while its Price-to-Book (P/B) ratio in mrq is 13.54. Its current Enterprise Value per Revenue stands at 6.803 whereas that against EBITDA is 32.006.

Stock Price History:

Over the past 52 weeks, DXCM has reached a high of $142.00, while it has fallen to a 52-week low of $62.34. The 50-Day Moving Average of the stock is -1.54%, while the 200-Day Moving Average is calculated to be -34.31%.

Shares Statistics:

The stock has traded on average 4.49M shares per day over the past 3-months and 5534400 shares per day over the last 10 days, according to various share statistics. A total of 385.40M shares are outstanding, with a floating share count of 385.37M. Insiders hold about 1.34% of the company’s shares, while institutions hold 96.19% stake in the company. Shares short for DXCM as of 1728950400 were 7684165 with a Short Ratio of 1.71, compared to 1726185600 on 8551679. Therefore, it implies a Short% of Shares Outstanding of 7684165 and a Short% of Float of 2.23.

Most Popular